Translate:

Twitter Facebook Linkedin

Search

Dr. Brian Koffman’s Blog

More Links

CLL Society

Patients and providers fighting CLL together

Smart Patients Get Smart Care™

Donate to CLL Society

Home
Basics
Beyond The Basics
Living Well With CLL
Clinical Trials
Conference Coverage
CAR-T
Support Groups/Education
News
About Us

CLL Society Patient & Caregiver Survey

You are here:

Home
CLL Society Patient & Caregiver Survey

Recent News

AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for VENCLEXTA®, a treatment for chronic lymphocytic leukemia (CLL)
May 29, 2019
May 15, 2019: FDA approved venetoclax in combination with obinutuzumab for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
May 20, 2019
Acalabrutinib Phase III ASCEND trial met primary endpoint at interim analysis in relapsed or refractory chronic lymphocytic leukemia and will stop early
May 10, 2019

Conference Coverage

ASH 2018: Professor Hoffbrand on 50 years of treating CLL (chronic lymphocytic leukemia)
July 18, 2019
ASH 2018: Dr. Yucai Wang on the Micro-Environment in CLL (chronic lymphocytic leukemia)
July 15, 2019
ASH 2018: Dr. Wang on Richter’s Transformation in CLL (chronic lymphocytic leukemia)
June 22, 2019
ASH 2018: Dr. Davids on The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in CLL (chronic lymphocytic leukemia)
June 17, 2019
ASH 2018: Dr. Tait Shanafelt on the ECOG-ACRIN Cancer Research Group trial comparing FCR and Ibrutinib/Rituximab in Treatment Naïve CLL (chronic lymphocytic leukemia) of younger patients.
June 13, 2019
ASH 2018: Dr. Nitin Jain on a fixed duration of Ibrutinib and Venetoclax in Treatment-Naïve High-Risk Chronic Lymphocytic Leukemia (CLL)
June 10, 2019

Chronic Lymphocytic Leukemia Toolbox

Abbreviations & Acronyms
Ask The Doctor
Ask The Pharmacist
Ask The Laboratory Scientist

Ask the Palliative Care/Hospice Doctor
Build-A-Team
CLL Doctors
CLL Glossary

CLL Links
Keeping Track Of
Lab Results
Normal Lab Values

Home
Basics
Beyond The Basics
Living Well With CLL
Clinical Trials
Conference Coverage
CAR-T
Support Groups/Education
News
About Us

Navigation

We’d like to thank our supporters:

AbbVie
AstraZeneca
Beigene
Celgene
Genentech/Biogen Idec
Gilead
Juno
Pharmacyclics/Janssen
Sunesis Pharmaceuticals
TG Therapeutics
Verastem

Copyright 2019 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy

This site uses cookies: Find out more.